ALFA Filings
Every announcement, straight from the exchange
Every Indoco Remedies other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements with these filters
Indoco Remedies Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in accordance with SEBI Regulation 31(1)(b).
Indoco Remedies disclosed an unsolicited Crisil ESG rating of 'Crisil ESG 60'. The company notes it did not engage Crisil for the assessment.
Indoco Remedies has filed its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-2026. The report provides disclosures on ESG, operations, and governance.
Indoco Remedies submitted its Annual Secretarial Compliance Report for FY2025-26. The auditor confirmed adherence to SEBI regulations and statutory provisions without any adverse observations.